The Anaphylaxis Campaign recently became aware of news reports in the media stating that major supermarkets had introduced new social distancing rules in store, asking customers not to touch food items unless they intended to buy them, and suggesting that

Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, had previously experienced manufacturing challenges which resulted in interruptions in the supply of EpiPen Jr 0.15mg and EpiPen 0.3mg Adrenaline Auto-Injectors (AAIs). Supply has stabilised further in

The Anaphylaxis Campaign is aware of a number of companies offering intravenous vitamins which they claim can boost nutritional wellbeing. As a charity that supports the allergic community, we have concerns about the potential risks of these treatments should the companies

Our 2019 impact report is now available to view online. Every year we look back at the differences we have made to the allergic community and announce our vision for the future. In 2019 we celebrated our 25th anniversary and

7th April 2020 This is a different alert to that issued on 04 March 2020 for Emerade 150 microgram auto-injectors. The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received updated information from the company that

On the 23rd March 2020 the government announced that all restaurants, pubs and cafés would have to close as part of measures to combat the spread of the novel coronavirus. The government has temporarily relaxed planning rules for these food

The Anaphylaxis Campaign is deeply saddened to learn of the death of its Honorary President, Dr. William Frankland, who died today (2 April 2020) at the age of 108. Throughout his life, Dr. Frankland worked to improve the lives of

With concerns from the allergic community about the lack of availability of FreeFrom and alternative foods during the coronavirus pandemic, The Anaphylaxis Campaign would like to share the following statement from Nutricia Paediatric regarding the availability of specialist formula: For

The Anaphylaxis Campaign, the only UK wide charity operating solely for the growing numbers of people at risk from severe allergic reactions and anaphylaxis, has heard increasing concerns from the allergic community about the availability of FreeFrom and alternative foods